Literature DB >> 11904750

Disentangling the pathology of schizophrenia and paraphrenia.

Manuel F Casanova1, Janice R Stevens, Rosemary Brown, Claire Royston, Clive Bruton.   

Abstract

With increasing longevity, the number of older schizophrenic patients is growing. Previous criteria used the age of symptom onset to differentiate between the late manifestations of early-onset schizophrenia and late-onset schizophreniform disorders. Current DSM-IV or ICD 10 nomenclatures do not differentiate between early- and late-onset schizophrenia. Many decades of repeated failures to provide for distinguishing neuropathological findings have prompted narrower definition criteria. Since psychotic or schizophreniform symptoms in old age may be a manifestation of Alzheimer's disease, we attempted to base a distinction between both early- and late-onset schizophrenia on the presence of degenerative changes. This study examined the brains of 64 schizophrenic patients and 18 controls immunocytochemically for tau and amyloid staining. We divided patients according to their ages at the onset of symptoms: <40, >40. Using Braak's classification, we assessed the presence of neurofibrillary pathology. Stages III and IV were observed in 11.1% (2/18) of controls, 36.7% (11/30) of early-onset schizophrenics (<40) and 58.8% (20/34) of late-onset (>40) schizophrenics (chi2=11.39, P =0.003). Stages V and VI (definite Alzheimer's disease) did not significantly differ among groups (chi2=3.6, P =0.165). Astrocytes, subependymal and fibroblastic, also exhibited tau-positive tangles. Chi-square analysis of the data revealed a significant association between tau-positive glial tangles and Braak staging ( P =0.002). Amyloid deposits were sparse in comparison to tau-related changes. The restricted limbic tauopathy not only affected a majority of patients with late-onset schizophrenia (19 female: 1 male among positive cases) ( P =0.048) but also appeared in one-third of those elderly schizophrenic patients whose symptom onset occurred before 40 years of age (8 female: 3 male among positive cases) ( P =0.048). The resultant changes define a type of neuronal cytoskeletal disruption that alters the flow of information through the hippocampus and provides a useful clinico-pathological correlate to a group of patients until recently diagnosed as schizophrenic.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11904750     DOI: 10.1007/s00401-001-0468-6

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  9 in total

Review 1.  The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications.

Authors:  Paul J Harrison
Journal:  Psychopharmacology (Berl)       Date:  2004-03-06       Impact factor: 4.530

Review 2.  The pathology of paraphrenia.

Authors:  Manuel F Casanova
Journal:  Curr Psychiatry Rep       Date:  2010-06       Impact factor: 5.285

Review 3.  Β-Amyloid Burden is Not Associated with Cognitive Impairment in Schizophrenia: A Systematic Review.

Authors:  Jun Ku Chung; Shinichiro Nakajima; Eric Plitman; Yusuke Iwata; Danielle Uy; Philip Gerretsen; Fernando Caravaggio; M Mallar Chakravarty; Ariel Graff-Guerrero
Journal:  Am J Geriatr Psychiatry       Date:  2016-04-29       Impact factor: 4.105

4.  miR-132/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo.

Authors:  Pascal Y Smith; Julia Hernandez-Rapp; Francis Jolivette; Cynthia Lecours; Kanchan Bisht; Claudia Goupil; Veronique Dorval; Sepideh Parsi; Françoise Morin; Emmanuel Planel; David A Bennett; Francisco-Jose Fernandez-Gomez; Nicolas Sergeant; Luc Buée; Marie-Ève Tremblay; Frédéric Calon; Sébastien S Hébert
Journal:  Hum Mol Genet       Date:  2015-09-11       Impact factor: 6.150

5.  Hippocampal abnormalities and age in chronic schizophrenia: morphometric study across the adult lifespan.

Authors:  N Pujol; R Penadés; C Junqué; I Dinov; C H Y Fu; R Catalán; N Ibarretxe-Bilbao; N Bargalló; M Bernardo; A Toga; R J Howard; S G Costafreda
Journal:  Br J Psychiatry       Date:  2014-09-11       Impact factor: 9.319

6.  Argyrophilic grain disease as a neurodegenerative substrate in late-onset schizophrenia and delusional disorders.

Authors:  Shigeto Nagao; Osamu Yokota; Chikako Ikeda; Naoya Takeda; Hideki Ishizu; Shigetoshi Kuroda; Koichiro Sudo; Seishi Terada; Shigeo Murayama; Yosuke Uchitomi
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-11-23       Impact factor: 5.270

7.  Characteristics of very late-onset schizophrenia-like psychosis as prodromal dementia with Lewy bodies: a cross-sectional study.

Authors:  Hideki Kanemoto; Yuto Satake; Takashi Suehiro; Daiki Taomoto; Fuyuki Koizumi; Shunsuke Sato; Tamiki Wada; Keiko Matsunaga; Eku Shimosegawa; Mamoru Hashimoto; Kenji Yoshiyama; Manabu Ikeda
Journal:  Alzheimers Res Ther       Date:  2022-09-22       Impact factor: 8.823

8.  Astrocytic mechanisms explaining neural-activity-induced shrinkage of extraneuronal space.

Authors:  Ivar Østby; Leiv Øyehaug; Gaute T Einevoll; Erlend A Nagelhus; Erik Plahte; Thomas Zeuthen; Catherine M Lloyd; Ole P Ottersen; Stig W Omholt
Journal:  PLoS Comput Biol       Date:  2009-01-23       Impact factor: 4.475

9.  Electrodiffusive model for astrocytic and neuronal ion concentration dynamics.

Authors:  Geir Halnes; Ivar Ostby; Klas H Pettersen; Stig W Omholt; Gaute T Einevoll
Journal:  PLoS Comput Biol       Date:  2013-12-19       Impact factor: 4.475

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.